Growth Metrics

Cryo Cell International (CCEL) Cost of Revenue (2016 - 2026)

Cryo Cell International's Cost of Revenue history spans 17 years, with the latest figure at $1.7 million for Q1 2026.

  • Quarterly results put Cost of Revenue at $1.7 million for Q1 2026, down 16.53% from a year ago — trailing twelve months through Feb 2026 was $7.0 million (down 9.31% YoY), and the annual figure for FY2025 was $7.4 million, down 7.19%.
  • Cost of Revenue for Q1 2026 was $1.7 million at Cryo Cell International, down from $1.7 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $2.3 million in Q3 2022 to a low of $1.6 million in Q4 2024.
  • The 5-year median for Cost of Revenue is $2.1 million (2024), against an average of $2.0 million.
  • The sharpest move saw Cost of Revenue dropped 19.13% in 2024, then grew 5.95% in 2025.
  • Year by year, Cost of Revenue stood at $2.1 million in 2022, then dropped by 5.38% to $2.0 million in 2023, then dropped by 19.13% to $1.6 million in 2024, then increased by 5.95% to $1.7 million in 2025, then decreased by 4.48% to $1.7 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods came in at $1.7 million, $1.7 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.